J. Schold

American Journal of Transplantation · 2004

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from J. Schold's perspective

Ordered by how strongly the researchers J. Schold trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Improved graft survival after renal transplantation in the United States, 1988 to 1996. (New England Journal of Medicine)
  2. Nonparametric Estimation from Incomplete Observations
  3. Improved graft survival after renal transplantation in the United States, 1988 to 1996. (New England Journal of Medicine)
  4. Surgical risk factors, morbidity, and mortality in elderly patients. (Journal of the American College of Surgeons)
  5. Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties (American Journal of Transplantation)
  6. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus (American Journal of Transplantation)
  7. The natural history of chronic allograft nephropathy. (Journal of Urology)
  8. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era (American Journal of Transplantation)
  9. Reduced exposure to calcineurin inhibitors in renal transplantation. (New England Journal of Medicine)
  10. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (Nature Medicine)

Their papers